Quick Answer
MARAVAI LIFESCIENCES HOLDINGS, INC. reported R&D Expense of $17.40 million for fiscal year 2025.
MARAVAI LIFESCIENCES HOLDINGS, INC. R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2025 | $17.40M | -9.5% |
| 2024 | $19.22M | +11.2% |
| 2023 | $17.28M | -5.9% |
| 2022 | $18.37M | +20.7% |
| 2021 | $15.22M | +63.6% |
| 2020 | $9.30M | +156.5% |
| 2019 | $3.63M | — |
Quarterly R&D Expense
| Quarter Ending | R&D Expense | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $3.84M | -18.3% | -21.3% |
| June 30, 2025 | $4.88M | -0.9% | -0.1% |
| March 31, 2025 | $4.89M | -2.9% | +3.9% |
| September 30, 2024 | $4.70M | +8.2% | -4.5% |
| June 30, 2024 | $4.92M | +17.4% | -2.1% |
| March 31, 2024 | $5.03M | +21.4% | +15.8% |
| September 30, 2023 | $4.35M | -19.3% | +3.6% |
| June 30, 2023 | $4.19M | -1.9% | +1.2% |
- MARAVAI LIFESCIENCES HOLDINGS, INC. showed a decrease of -9.5% in R&D Expense compared to the prior fiscal year.
- Over the 2019–2025 period, MARAVAI LIFESCIENCES HOLDINGS, INC.’s r&d expense has grown by 379.8% (from $3.63 million to $17.40 million).
- The most recent figure is from MARAVAI LIFESCIENCES HOLDINGS, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: